accurately identify the cancer. Recent trends in genetics, molecular diagnostics and the liquid biopsy are shaping every aspect of oncology today. Liquid biopsy and related technologies have expanded the study ... tumor…
cancer diagnostics and treatment is undergoing a transformative shift with the advent of liquid biopsy technology. Unlike traditional tissue biopsies, which require invasive procedures to obtain tumor samples, liquid…
treatment. Hence, we are seeking to establish a complementary patient selection process based on liquid biopsies using a simple blood draw. Based on the analysis of circulating tumor cells (CTCs ... ctDNA), or…
tumor-specific molecular aberrations in the ccf-DNA is performed, what is called liquid biopsy. Many studies reported increased serum concentration and DNA integrity index in various solid tumors including ... claimed…
information key for devising personalized therapeutic strategies for managing disease in cancer patients. A liquid biopsy is emerging as a sensitive means to evaluate biomarker status without the complications…
Liquid biopsy has emerged as a promising non-invasive diagnostic approach for various diseases, particularly cancer. Unlike traditional tissue biopsies, which involve invasive procedures, liquid biopsy involves the…
have limitations, including invasiveness and the potential for sampling errors due to tumor heterogeneity. Liquid biopsies, a non-invasive diagnostic approach, have emerged as a promising tool for early detection…
Liquid biopsies are emerging as a transformative tool in the diagnosis and management of kidney cancer, offering a non-invasive alternative to traditional tissue biopsies. By analyzing circulating tumor ... ctDNA)…
Liquid biopsies have emerged as a transformative non-invasive diagnostic tool in oncology, providing a dynamic and comprehensive approach to cancer detection and monitoring. By analyzing biomarkers such as circulating…
Liquid biopsy represents a revolutionary paradigm shift in the field of cancer detection and monitoring. This non-invasive diagnostic approach leverages the analysis of various components in bodily fluids ... biomarkers…
positive IDH-mutated tumour DNA detected within CSF. Our results demonstrated the usefulness of liquid biopsy for recurrent glioma within the context of equivocal or negative histopathological results, whilst also…
Liquid biopsies represent a groundbreaking advancement in cancer diagnostics, offering a minimally invasive alternative to traditional tissue biopsies by analyzing biomarkers found in blood samples. This article…
Liquid biopsies, a groundbreaking advancement in diagnostic medicine, offer a non-invasive alternative to traditional tissue biopsies. This paper explores the integration of liquid biopsies into surgical pathology…
Liquid biopsy is an ingenious innovative technique which has the potential to provide information about cancers without invasive biopsy, using circulating biomarkers. A progressing cancer features heterogeneity and…
Liquid biopsy has emerged as a revolutionary technique in cancer diagnostics, offering a non-invasive approach to detect and monitor tumor dynamics through the analysis of circulating tumor DNA (ctDNA ... where…
Liquid biopsy, a minimally invasive diagnostic modality, has emerged as a transformative tool in the realm of oncology, particularly in the monitoring and management of bone and soft tissue tumors ... application, and…
Liquid biopsy has emerged as a revolutionary technique in the diagnosis, monitoring, and treatment of various cancers, particularly lung cancer. Unlike traditional biopsy methods, which involve invasive tissue…
tissue biopsy, which can be unstable methods for the patient. To overcome these challenges, liquid biopsy has end up a fascinating choice through constituting a safer manner than traditional biopsy ... existing complete…
Liquid biopsies have for long received enormous attention due to its clinical immediate application in daily practice. This short review focuses in how the detection of circulating tumour cells (CTCs ... across the most…
Liquid biopsies, particularly those analyzing circulating tumor DNA (ctDNA), have emerged as a non-invasive tool for diagnosis, monitoring, and treatment personalization in gynecologic cancers, including ovarian…
prognosis. Current growth cells (CTCs) are often used as a non-invasive “real-time liquid biopsy”, that has shown the worth of diagnosing, assessment of prognosis and chemo resistance ... with special specialize in the…
Applications of liquid biopsy are primarily to monitor treatment response and to detect secondary treatment resistant mutations. In patients with bone-dominant metastatic breast cancer it can be challenging ... patient…
directed towards exploring the diagnostic, prognostic as well as predictive potential of ctDNA (liquid biopsy) in cancer. All biological and technical aspects covering recent advances pertaining to analytical…
Background: Liquid biopsies are emerging as an important source of minimally invasive biomarkers, especially in metastatic castration resistant prostate cancer (mCRPC), where tumors are often inaccessible for biopsy…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.